Our tenth lab opens in Singapore

We’re excited to announce the opening of our tenth global sequencing lab, located in Singapore’s vibrant biomedical hub. The new site dramatically shortens turnaround times for researchers from Seoul to Sydney, delivering the world’s fastest, highest‑accuracy, and most cost-effective sequencing services.

Sequencing at the Speed of Modern Science

Plasmidsaurus was founded to help scientists work faster. Despite incredible advancements in DNA sequencing technology that have dramatically accelerated the speed and lowered the cost of sequencing genomes, many biomedical researchers are still using sequencing technologies from the 1970s to advance their daily experiments. Plasmidsaurus believes that scientists shouldn’t have to put up with slow turnaround times and unreliable or inconclusive results that stall their progress. 

Singapore has a thriving and growing research community, bolstered by a S$25B investment in Research, Innovation and Enterprise, including significant support for cell and gene therapy, healthcare, and epidemic preparedness. But researchers across the Asia-Pacific region are often stuck with sequencing options that take weeks and cost more than twice what scientists in the US and Europe can expect. The new lab reflects Plasmidsaurus’ mission to deliver the fastest and more reliable sequencing to accelerate R&D for biopharmaceutical companies, CDMOs, and advanced research institutions around the world.

Global reach, local impact

Plasmidsaurus’s network of labs benefits from the company’s innovation in molecular biology, laboratory automation, bioinformatics software, and logistics that drive incredible speed and industry-leading accuracy across a wide range of sequencing services. For researchers and biotech and pharma companies scaling up research and development, that translates to faster design-build-test cycles, more reliable results, and less time spent troubleshooting logistics.

"We love sequencing with Plasmidsaurus to validate clones,” said Jonathan Bester, co-founder of Singapore-based biotech startup Peptobiotics. “It's faster, less tedious, and more comprehensive than Sanger, translating to better and faster experiments and shorter R&D timelines overall. The new lab in Singapore is going to be a game-changer for us."